Annie Rassing Hoelgaard

Serum growth hormone (GH) profiles after nasally administered GH in normal subjects and GH deficient patients

OBJECTIVE GH‐deficient patients are at present treated with daily subcutaneous GH injections. Further improvements in patient compliance and effects of treatment may occur with nasal administration. We have examined the absorption of nasally administered GH in healthy subjects and In GH deficient patients in two separate studies.